Relationship between microvessel count and postoperative survival in patients with intrahepatic cholangiocarcinoma

Annals of Surgical Oncology

Volumn 16, Issue 8, 2009, Pages 2123-2129

  Nanashima, Atsushi ^a   Shibata, Kenichiro ^a   Nakayama, Toshiyuki ^a   Tobinaga, Syuichi ^a   Araki, Masato ^a   Kunizaki, Masaki ^a   Takeshita, Hiroaki ^a   Hidaka, Shigekazu ^a   Sawai, Terumitsu ^a   Nagayasu, Takeshi ^a   Tagawa, Tsutomu ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CD34 ANTIBODY;

ADULT; ADVANCED CANCER; ARTICLE; BILE DUCT CARCINOMA; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOMA; LIVER RESECTION; MALE; MICROVASCULATURE; POSTOPERATIVE PERIOD; PROGNOSIS; PROTEIN EXPRESSION; RISK FACTOR; SURVIVAL RATE; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ANTIGENS, CD34; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MICROCIRCULATION; MICROVESSELS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 67651007322     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0494-5     Document Type: Article

References (38)

1. T Sano K Shimada Y Sakamoto J Yamamoto S Yamasaki T Kosuge 2006 One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality Ann Surg. 244 240 247
2. N Kokudo M Makuuchi 2002 Extent of resection and outcome after curative resection for intrahepatic cholangiocarcinoma Surg Oncol Clin North Am. 11 969 983
3. S Miwa S Miyagawa A Kobayashi 2006 Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery J Gastroenterol. 41 893 900
4. Y Kawarada K Yamagiwa BC Das 2002 Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma Am J Surg. 183 679 685
5. D Tamandl B Herberger B Gruenberger 2008 Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma Ann Surg Oncol. 15 2787 2794
6. K Muenphon T Limpaiboon P Jearanaikoon 2006 Amplification of chromosome 21q22.3 harboring trefoil factor family genes in liver fluke related cholangiocarcinoma is associated with poor prognosis World J Gastroenterol. 12 4143 4148
7. BK Park YH Paik JY Park 2006 The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma Am J Clin Oncol. 29 138 142
8. B Zhai HX Yan SQ Liu 2008 Reduced expression of P120 catenin in cholangiocarcinoma correlated with tumor clinicopathologic parameters World J Gastroenterol. 14 3739 3744
9. P Thuwajit W Chawengrattanachot C Thuwajit 2008 Enhanced expression of mucin 6 glycoprotein in cholangiocarcinoma tissue from patients in Thailand as a prognostic marker for survival J Gastroenterol Hepatol. 23 771 778
10. K Itatsu Y Zen J Yamaguchi 2008 Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts Hum Pathol. 39 710 719
11. KJ Schmitz H Lang J Wohlschlaeger 2007 Elevated expression of cyclooxygenase-2 is a negative prognostic factor for overall survival in intrahepatic cholangiocarcinoma Virchows Arch. 450 135 141
12. MC Su C Hsu HL Kao YM Jeng 2006 CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma Cancer Lett. 235 34 39
13. Nathan H, Aloia TA, Vauthey JN, et al. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2008;16(1):14-22.
14. Y Cao 2008 Molecular mechanisms and therapeutic development of angiogenesis inhibitors Adv Cancer Res. 100 113 131
15. D Yoshikawa H Ojima M Iwasaki 2008 Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma Br J Cancer. 98 418 425
16. K Shirabe M Shimada E Tsujita 2004 Prognostic factors in node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis Am J Surg. 187 538 542
17. A Nanashima M Yoshinaga H Yamaguchi 2003 An immunohistochemical study of tumor vascularity and proliferation activity in cholangiocellular carcinoma: relationship to clinicopathologic factors and prognosis after hepatic resection Acta Med Nagasaki. 48 23 27
18. WR Jarnagin M Shoup 2004 Surgical management of cholangiocarcinoma Semin Liver Dis. 24 189 199
19. A Nanashima Y Sumida T Abo 2008 Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma J Surg Oncol. 98 535 539
20. D Tang H Nagano H Yamamoto 2006 Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance Oncol Rep. 15 525 532
21. A Nanashima H Yamaguchi T Sawai 2001 Prognostic factors in hepatic metastases of colorectal carcinoma: immunohistochemical analysis of tumor biological factors Dig Dis Sci. 46 1623 1628
22. A Nanashima T Nakayama Y Sumida 2008 Relationship between microvessel count and post-hepatectomy survival in patients with hepatocellular carcinoma World J Gastroenterol. 14 4915 4922
23. A Nanashima H Yamaguchi S Shibasaki 2006 Relationship between CT volumetry and functional liver volume using technetium-99 m galactosyl serum albumin scintigraphy in patients undergoing preoperative portal vein embolization before major hepatectomy: a preliminary study Dig Dis Sci. 51 1190 1195
24. Liver Cancer Study Group of Japan. Part I Clinical findings. In: Makuuchi M (editor) The general rules for the clinical and pathological study of primary liver cancer, 2nd English ed. Tokyo: Kanehara; 2003. p. 6-28.
25. A Nanashima H Yano H Yamaguchi 2004 Immunohistochemical analysis of tumor biological factors in hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection J Gastroenterol. 39 148 154
26. S Hai S Kubo S Yamamoto 2005 Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma Dig Surg. 22 432 439
27. KN Lazaridis GJ Gores 2005 Cholangiocarcinoma Gastroenterology. 128 1655 1667
28. SA Khan BR Davidson R Goldin 2002 Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document Gut. 51 1 9
29. HS Park JM Lee JY Choi 2008 Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography AJR Am J Roentgenol. 190 396 405
30. C Valls A Gumà I Puig 2000 Intrahepatic peripheral cholangiocarcinoma: CT evaluation Abdom Imaging. 25 490 496
31. SJ Kim JM Lee JK Han 2007 Peripheral mass-forming cholangiocarcinoma in cirrhotic liver AJR Am J Roentgenol. 189 1428 1434
32. S Seo E Hatano T Higashi 2008 Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma Surgery. 143 769 777
33. C Wise M Pilanthananond BF Perry 2008 Mechanisms of biliary carcinogenesis and growth World J Gastroenterol. 14 2986 2989
34. D Burke P Carnochan C Glover 2000 Correlation between tumour blood flow and fluorouracil distribution in a hypovascular liver metastasis model Clin Exp Metastasis. 18 617 622
35. S Miwa J Soeda S Miyagawa 2005 Interrelationship of platelet-derived endothelial cell growth factor, liver macrophages, and tumor microvessel density in patients with cholangiocellular carcinoma Hepatogastroenterology. 52 1398 1402
36. S Bergmann PP Pandolfi 2006 Giving blood: a new role for CD40 in tumorigenesis J Exp Med. 203 2409 2412
37. K Kozaka M Sasaki T Fujii 2007 A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma' Histopathology. 51 390 400
38. T Sano J Kamiya M Nagino 1999 Macroscopic classification and preoperative diagnosis of intrahepatic cholangiocarcinoma in Japan J Hepatobiliary Pancreat Surg. 6 101 107